Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by HuntNGatheron Mar 12, 2013 4:08pm
317 Views
Post# 21118269

RE: shares @ market price or prospectus?

RE: shares @ market price or prospectus?

Hello Schwat,

Everyone needs to make their own peace with this but I for one think that the share+warrant at .25/.40 is a great deal. I am putting my money where my mouth is too.

The fact that it has sold down in the last number of days since the announced terms is more of a knee jerk reaction among some who are skittish and also undoubtedly a move on the part of others to unload their shares at 30,29,28,27,26,25,24,23,22,21,20,19,18.5 cents then re-buy in the financing at 25 with a warrant that is good for 5 years.

Having the share+warrant priced at .25/.40 gave perhaps the false impression that the leaders believed that is what it is really worth. Well, from my perspective as a very interested non-insider, it is worth far more than that  given all that is going on but that price was set to entice some to belly up for the first time.... and for others to belly up again for more based on the emergent story. It had to be compelling or nobody would be willing to buy in the volumes needed to raise the capital to seal the Trillium deal which is time sensitive and a key to the plot of the SCT story. A quarter plus a warrant is compelling indeed.

Given that now is a time when the company has been the most exciting it has been in the last 2 years, leaving is a fools option in my mind. People with any sense are churning positions to make pennies up or down OR they are selling to re-buy in the financing.  Those who are quietly accumulating (like me, with the exception of the occassional rant or rave on Stockhouse) are the backbone of the investor base.

The time to throw the teddy-bear in the corner and walk away mad was a long time ago. People who are here now feel the sun is about to come over the horizon again and want to stay for the show.... whatever it may bring.  Beautiful sunrise or a meteor... time will tell.

HnG

Bullboard Posts